Angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB) have been hypothetically suggested to exacerbate COVID-19 due to increase in angiotensin II level [31]. The gene discussed is AGT; the disease is COVID-19.